Tag: AxelaCare
'Changing landscape'
December 22, 2015Theresa Flaherty, Managing Editor
EDEN PRAIRIE, Minn. - OptumRx's recent purchase of AxelaCare Health Solutions, a home infusion services provider, points to a larger trend of both pharmacy benefit managers and payers bringing other services under their umbrellas, analysts say.
“This is the changing landscape in health care,” said Justin Ishbia, founder and managing partner of Shore Capital Partners, a private equity firm that used to own SCP Specialty Infusion. “They are the payer but they are also the provider...
PBM buys into home infusion
November 25, 2015Theresa Flaherty, Managing Editor
EDEN PRAIRIE, Minn. - OptumRx's recent purchase of home infusion services provider AxelaCare Health Solutions gives the pharmacy benefit manager a platform for a more integrated model, say analysts.
“OptumRx already has a specialty component and this gives them the infusion component, as well,” said Reg Blackburn, managing director of specialty pharmacy and infusion services for The Braff Group.
OptumRx is part of healthcare giant UnitedHealth Group. Other buys by the company...
In brief: Device maker buys Liberator, lawmakers seek complex rehab clarification
November 20, 2015HME News Staff
MURRAY HILL, N.J. - C.R. Bard, a manufacturer of medical devices for vascular, urology, oncology and surgical specialty fields, announced last week that it has acquired Liberator Medical for $181 million.
Liberator is a director-consumer-provider of home medical supplies, including catheters, ostomy, diabetes and mastectomy.
“As the population ages and more healthcare is expected to occur outside of the hospital setting, we believe that having direct access to the patient in the home...
OptumRx expands services with buy
November 19, 2015HME News Staff
EDEN PRAIRIE, Minn. - OptumRx, the pharmacy care services business owned by Optum, has acquired AxelaCare Health Solutions, a provider of home infusion solutions, the company announced this week. “AxelaCare's at-home services will enable us to more effectively support the growing number of people managing complex conditions, many of whom require infusions that increasingly involve higher-cost specialty medications," said Larry Renfro, Optum CEO, in a release. Founded in 2008,...
AxelaCare has patient care in its 'DNA'
March 28, 2014Theresa Flaherty, Managing Editor
LENEXA, Kan. - AxelaCare in February acquired ARC Infusion and has two more deals in the pipeline as it looks to pump up its geographic reach, say company execs.With the acquisition of the Los Angeles-based ARC, AxelaCare now has 15 pharmacies that stretch from the West Coast to the East Coast and provide both acute and chronic home infusion services.“It looks like the typical consolidation of a fragmented market, but the bigger benefit is really that care focus,” said David Schaefer,...
In brief: Report cites spike in PAP use, Inogen sets IPO terms
February 7, 2014HME News Staff
WASHINGTON - The number of beneficiaries receiving PAP devices for a one-year time period grew 13%, while the total number of beneficiaries receiving all DMEPOS items during the same period fell 1%, according to a recently released comparative billing report. Compiled by eGlobal Tech and Palmetto GBA, the report used data from claims processed by the DME MACs between July 2012 and June 2013. They also found allowed charges on PAP devices rose 23%, when allowed charges for all DMEPOS items fell by...
AxelaCare acquires ARC Infusion
February 5, 2014HME News Staff
LENEXA, Kan. - AxelaCare, a specialty home infusion provider, has acquired Los Angeles-based ARC Infusion, bringing its number of total pharmacies to 15, according to a release. “ARC Infusion is a great addition for us as it builds our presence in California in both the IG and acute home infusion markets” said Ted Kramm, AxelaCare CEO, in the release. “We are continuing to actively pursue acquisitions in California, as well as other states, to increase our geographic and product...
SCP, AxelaCare deal sets path to growth
January 24, 2014Theresa Flaherty, Managing Editor
CHICAGO - SCP Specialty Infusion wasn't looking for a buyer, but when the team at AxelaCare Health Solutions approached the company, the potential for growth was clear.
“With their dynamic growth and our footprint we thought that 1+1=3,” said Justin Ishbia, founder and managing partner of SCP's parent company Shore Capital Partners.
SCP Specialty Infusion launched in 2010 when Shore Capital Partners acquired Sirona Infusion as a platform. It now covers seven western states....
Private equity has appetite for home infusion
January 15, 2014Theresa Flaherty, Managing Editor
YARMOUTH, Maine - Demand for home infusion companies at both ends of the scale was strong in 2013, say analysts.“There's bigger deals and then there's the bolt-on acquisitions,” said Reg Blackburn, managing director of specialty pharmacy and infusion services for The Braff Group. “There's not a lot in the middle.”The big news in 2013 was the sale of Coram to CVS Caremark in November for $2.1 billion. Other notable deals include BioScrip's acquisitions of CarePoint Partners...
In brief: NGS details reasons for denials, TiLite shakes up representation
November 8, 2013HME News Staff
INDIANAPOLIS - Prior authorization requests submitted as part of the PMD demo are being denied because of conflicting information in face-to-face exams and other medical records, and insufficient face-to-face exam information, National Government Services (NGS) announced in a recent bulletin. The list of reasons covers denials as of Oct. 24. NGS says face-to-face exams often do not specify: how a PMD will sufficiently improve the beneficiary's daily life; what are the beneficiary's mobility...